Hosta

Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the Medical Device Amendment bars state common-law claims that challenge the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration.^[1]

It modified the rule in Medtronic, Inc. v. Lohr.^[2]

See also

• Eli Lilly & Co. v. Medtronic, Inc.
• FDA Preemption
• List of United States Supreme Court cases, volume 552

References

Further reading

• Korobkin, Russell (2007). "Who Should Protect the Public? The Supreme Court and Medical Device Regulation". New England Journal of Medicine. 357 (17): 1680–1681. doi:10.1056/NEJMp078142. PMID 17960010.

External links

• Text of Riegel v. Medtronic, Inc., 552 U.S. 312 (2008) is available from: Findlaw  Justia  Oyez (oral argument audio)